- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Antimullerian Hormone in Germany
Total 2074 results
-
Hoffmann-La RocheCompletedAnemiaItaly, Spain, Mexico, Hungary, Singapore, Greece, United Kingdom, Austria, Thailand, Germany, Poland, Russian Federation, Denmark, Brazil, Sweden, Czech Republic, Finland
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Cortendo ABCompletedEndogenous Cushing's SyndromeUnited States, Serbia, Denmark, Italy, Spain, Poland, Belgium, Bulgaria, Canada, Czechia, France, Germany, Israel, Netherlands, Turkey
-
Bristol-Myers SquibbCompletedSoft Tissue Sarcoma | Transitional Cell Carcinoma | Advanced Non-small Cell Lung Cancer | Gastric/Esophageal Adenocarcinoma | Pancreatic Cancer Including Ampulla of VaterUnited States, Argentina, Germany, Belgium, Canada, Poland, Netherlands, United Kingdom, France
-
AstraZenecaCompletedDiabetesUnited States, Mexico, Argentina, Brazil, Puerto Rico, Russian Federation, Germany, Italy, Ukraine, India, Hungary, Poland, Philippines
-
AmgenActive, not recruitingThyroid Eye DiseaseUnited States, Spain, Germany, Italy, France, United Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Poland, Germany, Bulgaria, Peru, Russian Federation, Mexico, Hungary, South Africa, Latvia, New Zealand, Costa Rica, India, Czechia, Romania, Lithuania, Puerto Rico, Chile
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Russian Federation, United Kingdom, Vietnam, Germany, Hungary, Finland, Norway, Netherlands, Slovakia, India
-
AstraZenecaTerminatedType 2 DiabetesItaly, United Kingdom, Germany, Philippines, Malaysia, Sweden, Finland, Canada, India, Australia, Singapore
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Adenoid Cystic Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Endometrial Neoplasms | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder Carcinoma | HER2 Negative Breast Neoplasms | Hormone Receptor Positive Breast NeoplasmsUnited States, Spain, Canada, United Kingdom, Germany, Italy
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Canada, El Salvador, Germany, Italy, Portugal, Russian Federation, Spain, Ukraine
-
PfizerCompletedDiabetes Mellitus, Type 2Germany, Netherlands, Sweden, Poland, Belgium, Finland, France, Norway, Spain, Switzerland
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Israel, Russian Federation, United Kingdom, Canada, Belgium, Germany, Australia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsUnited States, Korea, Republic of, Taiwan, France, United Kingdom, Belgium, Czechia, Germany, Poland
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, France, India, Turkey, United Kingdom, Mexico, Brazil, Germany, Hungary, Puerto Rico, Saudi Arabia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Puerto Rico, Mexico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, United Kingdom, Belgium, Norway, Germany, Greece
-
Novartis PharmaceuticalsCompletedCarcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non FunctioningSweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
-
SANUWAVE, Inc.CompletedDiabetic Foot UlcersUnited States, United Kingdom, Germany
-
Prof. Valérie Mc LinEuropean Society of Pediatric Gastroenterology, Hepatology and Nutrition; European... and other collaboratorsEnrolling by invitationCongenital Porto-Systemic Shunt (CPSS)Spain, United Kingdom, Canada, United States, Netherlands, France, Israel, Germany, Australia, Turkey, Switzerland, Japan, Belgium, Greece, Hungary, India, Italy
-
Boston Scientific CorporationUniversity of RochesterCompletedCardiovascular Disease | Diabetes Mellitus | TachycardiaSwitzerland, United States, Israel, Germany, Italy, Netherlands, Spain
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Denmark, Canada, France, Netherlands, Austria, Israel, Finland, Russian Federation, Croatia, Bulgaria, Poland, Ireland, Spain, Norway, Greece, Argentina, Germany
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Spain, Canada, Austria, Latvia, Slovakia, United Kingdom, Chile, Mexico, Netherlands
-
Eli Lilly and CompanyBerry Consultants; United BioSource, LLC; Tessella Inc.CompletedDiabetes Mellitus, Type 2United States, Korea, Republic of, Russian Federation, Puerto Rico, Romania, Spain, Taiwan, Mexico, France, Germany, India, Canada, Poland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Estonia, Germany, Latvia, Spain, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, United Kingdom, Canada, Spain, Denmark, Austria, Serbia, South Africa, Sweden, Italy, Bulgaria, Germany, Malaysia
-
Corcept TherapeuticsCompletedCushing SyndromeUnited States, Austria, Bulgaria, Canada, Germany, Israel, Italy, Netherlands, Poland, Romania, Spain
-
Lexicon PharmaceuticalsSanofiCompletedType 1 Diabetes MellitusIsrael, Italy, Spain, Bulgaria, Hungary, Poland, Slovakia, United Kingdom, Austria, Belgium, France, Germany, Lithuania, Netherlands, Romania, Sweden, Switzerland
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Germany, Greece, Denmark, France
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
PfizerCompletedAcromegalyCanada, United States, Spain, Germany, Sweden, Italy, Australia, Ireland, Norway, Brazil, United Kingdom, France, Greece
-
National Cancer Institute, NaplesActive, not recruitingOvarian CancerItaly, Belgium, Germany
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIsrael, Italy, United Kingdom, Denmark, Spain, Singapore, Taiwan, Germany, France, Hong Kong, Brazil
-
BayerCompletedChronic Kidney DiseaseSpain, Belgium, Austria, Germany, Bulgaria, Denmark, Italy, Israel, Sweden, Finland, Slovakia, Ukraine, Poland
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Netherlands, Austria, Spain, France, Germany, Ireland, Switzerland, Finland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela
-
TakedaCompletedDiabetes MellitusUnited States, Poland, Germany, Argentina, South Africa, Netherlands, Peru, Czech Republic, Brazil, Chile, Guatemala, Dominican Republic
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Spain, United Kingdom, Germany, Finland, Norway, Israel, Netherlands
-
Eli Lilly and CompanyRecruitingType 2 DiabetesTaiwan, United States, China, Mexico, Germany, Poland
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, United Kingdom, France, Netherlands, Finland, Germany, Sweden
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Croatia, Japan, Slovakia, Germany, Latvia, South Africa, Czechia, United Arab Emirates, Hungary, Ukraine, Puerto Rico
-
Hoffmann-La RocheCompletedPancreatic CancerBelgium, France, Germany, Italy, Spain, Australia, Canada, Czech Republic, Singapore, New Zealand, Austria, China, Netherlands, South Africa, United Kingdom, Israel, Peru, Finland, Poland, Taiwan, Sweden
-
PfizerCompletedThe Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)Diabetic Foot UlcerCanada, Austria, Czech Republic, Sweden, Russian Federation, Poland, Norway, United Kingdom, Italy, Belgium, Denmark, Germany, Greece, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
SanofiTerminatedSleep Initiation and Maintenance DisordersUnited States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong